APTAHEM AB has a total of 11 patent applications. Its first patent ever was published in 2009. It filed its patents most often in United States, EPO (European Patent Office) and Brazil. Its main competitors in its focus markets pharmaceuticals and biotechnology are RACTIGEN THERAPEUTICS, DITESAN LTD and AAL SCIENT INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 3 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Microorganisms | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Jedlina Luiza Anna | 6 |
#2 | Persson Tina | 3 |
#3 | Lindh Johan | 3 |
#4 | Luiza Anna Jedlina | 2 |
Publication | Filing date | Title |
---|---|---|
KR20200061337A | Nucleic acid molecule with anti-inflammatory and anticoagulant and long-term protective properties |